SCHEMBL30729255

SCHEMBL30729255

CC(C)[C@@H](N)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 6/20 0.60
ACE P12821 6/20 0.60
DPP7 Q9UHL4 5/20 0.60
REN P00797 4/20 0.60
FAP Q12884 3/20 0.60
DPP8 Q6V1X1 3/20 0.60
PREP P48147 2/20 0.60
DPP9 Q86TI2 2/20 0.60
PITRM1 Q5JRX3 1/20 0.60
KDM4E B2RXH2 1/20 0.60
F2 P00734 1/20 0.60
LMNA P02545 1/20 0.60
LTA4H P09960 1/20 0.60
MAPT P10636 1/20 0.60
PEPD P12955 1/20 0.60
ALOX15 P16050 1/20 0.60
PTGS1 P23219 1/20 0.60
HTR2A P28223 1/20 0.60
PTGS2 P35354 1/20 0.60
HRH1 P35367 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8212654 1.00 DPP4 (0.60) DPP4ACEDPP7RENFAP
SCHEMBL1647354 1.00 DPP4 (0.60) DPP4ACEDPP7RENFAP
SCHEMBL571628 1.00 DPP4 (0.60) DPP4ACEDPP7RENFAP
SCHEMBL30729305 1.00 DPP4 (0.60) DPP4ACEDPP7RENFAP
SCHEMBL22798144 0.95 DPP4 (0.55) DPP4ACEDPP7RENFAP
SCHEMBL22798147 0.95 DPP4 (0.55) DPP4ACEDPP7RENFAP
SCHEMBL25280669 0.94 DPP4 (0.55) DPP4ACEDPP7RENFAP
SCHEMBL1644891 0.94 DPP4 (0.55) DPP4ACEDPP7RENFAP
SCHEMBL31733880 0.94 DPP4 (0.55) DPP4ACEDPP7RENFAP
SCHEMBL1644894 0.94 DPP4 (0.55) DPP4ACEDPP7RENFAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250197441-A1 Safety-Catch Linkers for Solid Phase Peptide Synthesis AAPPTec, LLC (US) 2025-06-19 US disclosed
CN-113861268-B Cell penetrating peptides and methods of making and using the same 恩特拉达治疗学股份有限公司 2025-04-01 CN disclosed
CN-112041328-B Dipeptide and pharmaceutical composition containing the same 志瑞亚新药工业株式会社 2024-06-21 CN disclosed
CN-112041328-B Dipeptide and pharmaceutical composition containing the same 志瑞亚新药工业株式会社 2024-06-21 CN disclosed
JP-2024003144-A Pharmaceutical composition containing dipeptide ゼリア新薬工業株式会社 2024-01-11 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250197441-A1 Safety-Catch Linkers for Solid Phase Peptide Synthesis PNISR, SPPL2B, VIP DPP4 1243/4885ACE 1530/4885DPP7 571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.